3 Healthcare Stocks We’re Skeptical Of

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 3.7% gain for healthcare stocks has fallen short of the S&P 500’s 7.1% rise.